Astrotech Corporation (NASDAQ:ASTC – Get Free Report) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $3.54 and traded as high as $4.00. Astrotech shares last traded at $3.67, with a volume of 146,588 shares trading hands.
Analyst Ratings Changes
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Astrotech in a research report on Friday, March 27th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Astrotech has a consensus rating of “Sell”.
Get Our Latest Research Report on ASTC
Astrotech Stock Performance
Astrotech (NASDAQ:ASTC – Get Free Report) last posted its quarterly earnings results on Friday, February 13th. The aerospace company reported ($2.34) earnings per share (EPS) for the quarter. Astrotech had a negative return on equity of 68.53% and a negative net margin of 1,163.89%.The company had revenue of $0.15 million during the quarter.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Astrotech stock. Susquehanna International Group LLP bought a new position in shares of Astrotech Corporation (NASDAQ:ASTC – Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 13,539 shares of the aerospace company’s stock, valued at approximately $66,000. Susquehanna International Group LLP owned approximately 0.77% of Astrotech at the end of the most recent quarter. Institutional investors and hedge funds own 24.35% of the company’s stock.
About Astrotech
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
Recommended Stories
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
